CA Patent

CA2870134C — Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)

Assigned to Capsugel Belgium NV · Expires 2020-04-28 · 6y expired

What this patent protects

The present disclosure relates to aqueous composition comprising hydroxypropyl methyl cellulose acetate succinate (HPMCAS) polymer dispersed in water, wherein the dispersed polymer is partially neutralized with at least one alkaline material. The instant disclosure also relates t…

USPTO Abstract

The present disclosure relates to aqueous composition comprising hydroxypropyl methyl cellulose acetate succinate (HPMCAS) polymer dispersed in water, wherein the dispersed polymer is partially neutralized with at least one alkaline material. The instant disclosure also relates to compositions for use in methods of making capsule shells endowed with bulk enteric properties. The present disclosure also relates to capsules made according with the compositions and methods of the present disclosure.

Drugs covered by this patent

Patent Metadata

Patent number
CA2870134C
Jurisdiction
CA
Classification
Expires
2020-04-28
Drug substance claim
No
Drug product claim
No
Assignee
Capsugel Belgium NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.